N-(4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-4-(pyridin-4-yl)pyrimidin-2-amine

ID: ALA5316225

Max Phase: Preclinical

Molecular Formula: C37H50O16

Molecular Weight: 750.79

This compound is not in our inventory system

Associated Items:

Bioactivity Summary Target Summary Assay Summary

이름과 식별자

Canonical SMILES: C[C@@H]1[C@@H](C)[C@H](C)O[C@@H](O[C@@H]2[C@@H](O)[C@H](OCCc3ccc(O)c(O)c3)O[C@H](CO[C@@H]3OC[C@](O)(CO)[C@H]3O)[C@H]2OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1C

Standard InChI: InChI=1S/C37H50O16/c1-18-19(2)21(4)50-34(20(18)3)53-32-30(44)35(47-12-11-23-6-9-25(40)27(42)14-23)51-28(15-48-36-33(45)37(46,16-38)17-49-36)31(32)52-29(43)10-7-22-5-8-24(39)26(41)13-22/h5-10,13-14,18-21,28,30-36,38-42,44-46H,11-12,15-17H2,1-4H3/b10-7+/t18-,19-,20-,21+,28-,30-,31-,32-,33+,34+,35-,36-,37-/m1/s1

Standard InChI Key: OBJQKPXLHQUYSF-GMDSVFOVSA-N

Molfile:

     RDKit          2D

 54 58  0  0  0  0  0  0  0  0999 V2000
   -0.3560    0.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3584    1.3604    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0729    0.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0729    0.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3584   -0.2896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3560    0.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7872    1.3602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7872   -0.2895    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3584   -1.1144    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0703   -0.2895    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0703    1.3602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0703    2.1850    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5015    0.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2158    1.3602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9301    0.9479    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3558   -1.5268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7846    0.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4988   -0.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7846    0.9476    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2132    0.1228    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9274   -0.2895    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9276   -1.1143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6402   -1.5248    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3547   -1.1123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3562   -0.2916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6448    0.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0706    0.1207    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -6.0690   -1.5247    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3558   -2.3516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700   -2.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7844   -2.3515    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7844   -1.5268    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0701   -1.1144    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4986   -1.1144    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4986   -2.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0700   -3.5887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3584   -2.7640    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0727   -0.7021    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
    4.6445    1.3601    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3562    0.9482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3562    0.1232    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6463   -0.2884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9301    0.1195    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0706    1.3607    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    6.0706   -0.2891    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3560    2.5974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2698    3.4172    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5365    3.5887    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9487    2.8748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3970    2.2621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8094    1.5478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6629    3.2872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.6629    2.4624    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3772    2.8748    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  1  0
  3  7  1  1
  4  8  1  6
  5  9  1  0
  6 10  1  6
  1 11  1  1
 11 12  1  0
  7 13  1  0
 13 14  1  0
 14 15  1  0
 16  9  1  1
 10 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  2  0
 20 21  1  0
 22 21  2  0
 23 22  1  0
 24 23  2  0
 25 24  1  0
 26 25  2  0
 21 26  1  0
 25 27  1  0
 24 28  1  0
 29 16  1  0
 30 29  1  0
 31 30  1  0
 32 31  1  0
 33 32  1  0
 16 33  1  0
 32 34  1  6
 31 35  1  1
 30 36  1  6
 29 37  1  6
  5 38  1  6
 39 15  2  0
 40 39  1  0
 41 40  2  0
 42 41  1  0
 43 42  2  0
 15 43  1  0
 40 44  1  0
 41 45  1  0
 46 12  1  6
 47 46  1  0
 47 48  1  0
 48 49  1  0
 49 50  1  0
 50 46  1  0
 50 51  1  1
 49 52  1  1
 49 53  1  0
 53 54  1  0
M  END

Natural Product: No	Oral: No	Chemical Probe: No	Parenteral: No
Molecule Type:	Topical: No	First In Class: No	Black Box: No
Chirality: No	재고상태: No	Prodrug: No

Molecular Weight: 750.79	Molecular Weight (Monoisotopic): 750.3099	AlogP: 1.27	#Rotatable Bonds: 13
Polar Surface Area: 243.52	Molecular Species: NEUTRAL	HBA: 16	HBD: 8
#RO5 Violations: 3	HBA (Lipinski): 16	HBD (Lipinski): 8	#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.01	CX Basic pKa: ┄	CX LogP: 3.36	CX LogD: 3.35
Aromatic Rings: 2	Heavy Atoms: 53	QED Weighted: 0.08	Np Likeness Score: 1.80

N-(4-(4-methylpiperazin-1-yl)-3-(trifluoromethyl)phenyl)-4-(pyridin-4-yl)pyrimidin-2-amine

이름과 식별자

Alternative Forms

관련 대상(인간)

관련 대상(비인간)

Molecule Features

Drug Indications

작용 메커니즘

Calculated Properties

참고 문헌

Source

1. Wlodarchak N, Feltenberger JB, Ye Z, Beczkiewicz J, Procknow R, Yan G, King TM, Golden JE, Striker R.. (2021) Engineering Selectivity for Reduced Toxicity of Bacterial Kinase Inhibitors Using Structure-Guided Medicinal Chemistry., 12 (2.0): [PMID:35035774] [10.1021/acsmedchemlett.0c00580]
2. Lopes JPB, Silva L, Lüdtke DS.. (2021) An overview on the synthesis of carbohydrate-based molecules with biological activity related to neurodegenerative diseases., 12 (12.0): [PMID:35028560] [10.1039/D1MD00217A]